Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Clinical Rheumatology
Published in: Clinical Rheumatology 2/2006

01-03-2006 | Original Article

Clinical significance of IgA anticardiolipin and anti-β2-GP1 antibodies in patients with systemic lupus erythematosus and primary antiphospholipid syndrome

Authors: M. Samarkos, K. A. Davies, C. Gordon, S. Loizou

Published in: Clinical Rheumatology | Issue 2/2006

Login to get access
Metadata
Title
Clinical significance of IgA anticardiolipin and anti-β2-GP1 antibodies in patients with systemic lupus erythematosus and primary antiphospholipid syndrome
Authors
M. Samarkos
K. A. Davies
C. Gordon
S. Loizou
Publication date
01-03-2006
Publisher
Springer-Verlag
Published in
Clinical Rheumatology / Issue 2/2006
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-005-1156-z

Other articles of this Issue 2/2006

Clinical Rheumatology 2/2006 Go to the issue

Original Article

Association of systemic and thyroid autoimmune diseases

Original Article

A brief history of medical taxonomy and diagnosis

Original Article

Possible effect of subclinical inflammation on daily life in familial Mediterranean fever

Case Report

Aseptic meningitis and ischemic stroke in relapsing polychondritis

Case Report

Concurrent occurrence of Sweet’s syndrome and erythema nodosum: an overlap in the spectrum of reactive dermatoses

Erratum

Erratum to: Successfully living with chronic arthritis
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits